Amphastar P (AMPH)
- Exchange
- NASDAQ
- Symbol
- AMPH
- Sector
- Life Sciences
- Industry
- Pharmaceutical Preparations
- Description
- Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company is headquartered in Rancho Cucamonga, California.
- Country
- USA
Stock price
At close: November 20, 2024
-
Open43.71
-
High44.54
-
Low43.09
-
Close44.09
-
Volume607,136
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
2.77
Receivables turnover
5.61
Payables turnover
11.53
Working capital turnover
2.44
Days of inventory on hand (DOH)
131.72
Days of sales outstanding (DSO)
65.11
Number of days of payables
31.66
Fixed asset turnover
2.28
Total asset turnover
0.43
Current ratio
2.17
Quick ratio
1.65
Cash ratio
1.14
Cash conversion cycle
165.16
Debt-to-assets ratio
0.40
Debt-to-capital ratio
0.49
Debt-to-equity ratio
0.94
Financial leverage ratio
2.37
Interest coverage
7.24
Gross profit margin
54.49%
Operating profit margin
30.57%
Pretax margin
26.28%
Net profit margin
21.34%
Operating return on assets (Operating ROA)
13.02%
Return on assets (ROA)
9.09%
Return on total capital
15.82%
Return on equity (ROE)
21.51%